Gunnison Copper (TSX:GCU,OTCQB:EXMGF) is shifting its development strategy for the Gunnison copper project in Arizona, US, laying out plans for a conventional open-pit and heap-leach operation. In a preliminary economic assessment (PEA), released on Thursday (November 14), the company explains that it is targeting the production of finished copper cathode for domestic consumption. The PEA […]Read More

Gunnison Copper (TSX:GCU,OTCQB:EXMGF) is shifting its development strategy for the Gunnison copper project in Arizona, US, laying out plans for a conventional open-pit and heap-leach operation. In a preliminary economic assessment (PEA), released on Thursday (November 14), the company explains that it is targeting the production of finished copper cathode for domestic consumption. The PEA […]Read More

Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for the full ASX Release This post appeared first on investingnews.comRead More

Lightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at the Company’s recently acquired Esperança project. The discovery supports the Company’s approach to exploration in the district and its positive assessment of the prospectivity within the Lithium Valley region Minas Gerais, Brazil. The discovery has […]Read More

Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101 Phase 2a/b clinical trial in dengue fever. All key data samples have been collected following dosing of all subjects in the Phase 2a (prophylactic) trial as part of Island’s ISLA-101 Phase 2a/b PROTECT […]Read More

Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting the company’s achievements while waiting for the completion of its listing on the NASDAQ expected at the end of 2024. Canevari provided some updates about the joint venture with MD Anderson Cancer […]Read More

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce that a clinical study featuring 68Ga-Trivehexin (68Ga-RAD 301), conducted by Dr. Rehm and colleagues from the Technische Universität Dresden, has now been published in Frontiers in Nuclear […]Read More

Ionic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned subsidiary Ionic Technologies is on track for the development of a unique commercial REO manufacturing facility in Belfast, UK, following the successful completion of a Feasibility Study that demonstrates both strong financial returns and environmental sustainability. The study positions Ionic Technologies as the […]Read More

Perth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation by investee Cortical Dynamics at the Health Innovation Frontier Forum on 18th November 2024. This event will showcase the intersection between technology, health and community. *To view the presentation, please visit: https://abnnewswire.net/lnk/91TD2JM9 About BPH Energy Limited:   BPH Energy Limited (ASX:BPH) is an […]Read More

Bitcoin reached new heights this week, then paused amid speculation about how high it could go. Meanwhile, the Biden administration finalized a multibillion-dollar deal to bring advanced semiconductor manufacturing back to the US, and a nuclear energy company backed by Sam Altman announced data center supply deals. 1. Bitcoin price reaches new all-time high Bitcoin’s […]Read More